NorthWest Biotherapeutics Inc (NWBO)

[jimmy667]

As ae kusterer deduced the most logical reason for the delay in TLD is it will be published in a top peer reviewed medical journal likely with a PR simply stating our TLD is now published in "X" journal with appropriate summary.
This benefits patients most as it will be quicker to be embraced by Doctors and likely receive better handling by regulatory agencies and therefore speed availability.
It will silence the nefarious and otherwise skeptical critics and short sell the news crowd therefore be less distracting to the business of helping the primary beneficiaries, the patients.
All of this will benefit the tertiary beneficiaries the shareholders whether it is published this December or any reasonable month there after.
Putting this in the perspective of what will be the best for those souls with this very aggressive cancer makes the wait not just bearable but sweet.